This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Pfizer Corporation, Pfizer Products Inc.. Active years: 2010-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2010-2014
Title: James Alfred Southers, Jr.: Innovator in Pharmaceutical Chemistry
Introduction
James Alfred Southers, Jr. is a notable inventor based in Norwich, CT (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating abnormal cell growth.
Latest Patents
Southers holds 2 patents that showcase his innovative work. His latest patents include "Substituted acetyl-coa carboxylase inhibitors," which provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof. Another significant patent is for "Pyrimidine derivatives for the treatment of abnormal cell growth." This invention relates to a compound of a specific formula, which is useful in treating conditions such as cancer in mammals, especially humans. The invention also encompasses methods of using these compounds in treatment and pharmaceutical compositions containing them.
Career Highlights
Throughout his career, Southers has worked with prominent companies in the pharmaceutical industry, including Pfizer Corporation and Pfizer Products Inc. His work has contributed to advancements in drug development and therapeutic applications.
Collaborations
Southers has collaborated with notable professionals in his field, including Samit Kumar Bhattacharya and Michael Luzzio. These collaborations have likely enhanced the scope and impact of his research and inventions.
Conclusion
James Alfred Southers, Jr. is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations in the treatment of abnormal cell growth. His contributions continue to influence the field and offer hope for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile